Risk Clinical Stratification of Sickle Cell Disease in Nigeria, Assessment of Efficacy/Safety of Hydroxyurea Treatment

NCT02149537 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease
Sickle Cell Anemia

Interventions

DRUG: hydroxyurea

Sponsor

Loyola University

Collaborators

[object Object]
[object Object]